NIDDK's Diabetes Grant Huddle: Open for Some Snooping
Published Date: 6/6/2025
Notice
Summary
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is holding a public meeting on October 8-9, 2025, to discuss important research and review grant applications. Scientists and researchers applying for funding will be affected, as their work and qualifications will be evaluated. The meeting is partly open to the public online, with no direct money changes announced but important decisions on research support are expected.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
NIDDK grant review for applicants
If you are a scientist or researcher applying for NIDDK funding, your grant application and personal qualifications will be reviewed during the closed session on October 9, 2025 from 10:00 a.m. to 5:00 p.m. The Board of Scientific Counselors will evaluate individual investigators’ qualifications and competence, and important decisions on research support are expected.
Public videocast and accommodations
The meeting is open to the public on October 8, 2025 from 10:00 a.m. to 5:00 p.m. and can be accessed via the NIH Videocast at https://videocast.nih.gov/. Individuals who plan to attend and need special assistance (for example, sign language interpretation) should notify the contact person Michael W. Krause, Ph.D., at (301) 402-4633 or [email protected] in advance.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06501 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a cool new invention—special human antibodies that can fight certain cancers and autoimmune diseases—for companies to license and develop into treatments. This means businesses can jump on this opportunity to create powerful new medicines using government-backed research. Interested parties should act soon and may need to sign agreements to get full details.
2026-06283 — Prospective Grant of an Exclusive Patent License: Pigment Epithelium-Derived Factor (PEDF) Peptides and Use for Treating Retinal Degeneration
The National Eye Institute plans to give Perpetual Biosciences, Inc. an exclusive license to use special PEDF peptides to treat eye diseases that cause vision loss. This means the company will have the sole right to develop and sell this promising treatment, potentially helping millions with retinal degeneration. If you want to comment or apply for a license, act fast—submissions close April 16, 2026!
2026-05957 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in April 2026 to review and decide on important research grant applications. These meetings affect scientists seeking funding in areas like neuroscience, cancer, and liver disease. No public access is allowed to protect private info and trade secrets, and these reviews help decide where millions in research money will go.
2026-05672 — National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings
The National Institute on Deafness and Other Communication Disorders is holding two closed meetings in late April and early May 2026 to review grant applications and evaluate researchers’ qualifications. These meetings affect scientists seeking funding and help ensure top-notch research gets supported. No public access means privacy is protected, and the process keeps the money flowing to the best projects on time.
2026-05673 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on April 17, 2026, to review and evaluate important grant applications in health and science fields. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-05738 — Submission for OMB Review; 30-Day Comment Request; National Institutes of Health (NIH) Loan Repayment Programs, (Office of the Director)
The NIH is asking for a 30-day public comment on extending its Loan Repayment Programs that help doctors and scientists pay off their student loans while they do important health research. This extension keeps the program running smoothly with no big changes, and comments are due by April 23, 2026. If you’re a researcher with student loans, this program could save you money while you help improve health!
Previous / Next Documents
Previous: 2025-10334 — National Institute of General Medical Sciences; Cancellation of Meeting
The National Institute of General Medical Sciences canceled a special meeting set for July 1, 2025, about Tribal Institutional Review Board awards. This meeting was moved from the National Cancer Institute to the Center for Scientific Review, so folks involved should watch for updates on when and where reviews will happen. No money changes or delays were mentioned, but staying tuned is key!
Next: 2025-10336 — National Cancer Institute; Notice of Meeting
The National Cancer Institute is hosting a virtual meeting on July 16, 2025, to talk about their latest cancer research and clinical trials. Anyone interested can join online, share their thoughts, and learn about new plans that could shape cancer treatments. This is a great chance for researchers, patients, and the public to get involved without leaving home!
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in